A pilot study of lenalidomide maintenance therapy after autologous transplantation in relapsed or refractory classical Hodgkin lymphoma

For patients with relapsed or refractory classical Hodgkin lymphoma (cHL), salvage chemotherapy followed by consolidation with autologous stem cell transplant (ASCT) remains the standard of care. Even with this aggressive treatment strategy, 5-year progression-free survival is ≤ 50%, and there remai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Shea, Lauren, Watkins, Marcus P., Wan, Fei, Cashen, Amanda, Wagner-Johnston, Nina, Jacoby, Meagan, Abboud, Camille, Dipersio, John, Hurd, David, Jaglowski, Samantha, Bartlett, Nancy L., Fehniger, Todd
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8212249/
https://ncbi.nlm.nih.gov/pubmed/32829079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.08.017
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados